candesartan
Selected indexed studies
- Candesartan. (Cardiovasc Drug Rev, 2004) [PMID:15592574]
- Candesartan for Treatment of Migraine Headache: A Scoping Review. (Clin Ther, 2025) [PMID:40571531]
- Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. (Lancet Neurol, 2025) [PMID:40975098]
_Worker-drafted node — pending editorial review._
Connections
candesartan is a side effect of
Sources
- Candesartan. (2004) pubmed
- Candesartan for Treatment of Migraine Headache: A Scoping Review. (2025) pubmed
- Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. (2025) pubmed
- Candesartan in heart failure. (2006) pubmed
- Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials. (2023) pubmed
- Candesartan for the treatment of hypertension and heart failure. (2004) pubmed
- Clinical pharmacokinetics of candesartan. (2002) pubmed
- Candesartan for the prevention and treatment of stroke - results of the SCOPE and ACCESS trials. (2004) pubmed
- Candesartan Mitigates Perioperative Neurocognitive Disorders by Modulating Hypertension-Linked Neuroinflammatory Factor. (2025) pubmed
- Candesartan and renal protection: more than blocking angiotensin type 1 receptor? (2008) pubmed